KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Change in Cash (2016 - 2026)

Globus Medical filings provide 15 years of Change in Cash readings, the most recent being $154.4 million for Q4 2025.

  • On a quarterly basis, Change in Cash fell 4.51% to $154.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$258.3 million, a 181.44% decrease, with the full-year FY2025 number at -$258.3 million, down 181.44% from a year prior.
  • Change in Cash hit $154.4 million in Q4 2025 for Globus Medical, up from $142.3 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $212.3 million in Q3 2024 to a low of -$323.2 million in Q1 2025.
  • Median Change in Cash over the past 5 years was $46.5 million (2022), compared with a mean of $14.3 million.
  • The widest YoY moves for Change in Cash: up 7165.24% in 2021, down 1405.86% in 2021.
  • Globus Medical's Change in Cash stood at -$168.8 million in 2021, then soared by 109.62% to $16.2 million in 2022, then soared by 1055.4% to $187.7 million in 2023, then fell by 13.85% to $161.7 million in 2024, then decreased by 4.51% to $154.4 million in 2025.
  • The last three reported values for Change in Cash were $154.4 million (Q4 2025), $142.3 million (Q3 2025), and -$231.8 million (Q2 2025) per Business Quant data.